1. Home
  2. VRME vs IMNN Comparison

VRME vs IMNN Comparison

Compare VRME & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VerifyMe Inc.

VRME

VerifyMe Inc.

N/A

Current Price

$0.65

Market Cap

9.2M

Sector

Technology

ML Signal

N/A

Logo Imunon Inc.

IMNN

Imunon Inc.

N/A

Current Price

$1.40

Market Cap

9.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VRME
IMNN
Founded
1999
1982
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2M
9.1M
IPO Year
2013
2000

Fundamental Metrics

Financial Performance
Metric
VRME
IMNN
Price
$0.65
$1.40
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$1.50
$10.00
AVG Volume (30 Days)
45.2K
94.9K
Earning Date
05-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,398,000.00
N/A
Revenue This Year
$36.85
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.59
$1.39
52 Week High
$1.51
$5.71

Technical Indicators

Market Signals
Indicator
VRME
IMNN
Relative Strength Index (RSI) 49.89 34.46
Support Level $0.61 N/A
Resistance Level $0.74 $2.18
Average True Range (ATR) 0.03 0.11
MACD -0.00 -0.01
Stochastic Oscillator 42.97 17.81

Price Performance

Historical Comparison
VRME
IMNN

About VRME VerifyMe Inc.

VerifyMe Inc is a logistics company that specializes in time and temperature-sensitive products, as well as providing brand protection and enhancement solutions. The company operates through two reportable business segments: Precision Logistics offers a value-added service provider for time and temperature-sensitive parcel management. Using a proprietary IT platform, it provides real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries; and the Authentication segment specializes in anti-counterfeit and brand protection. The Precision Logistics segment derives the majority of the revenue.

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.

Share on Social Networks: